MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway
Authors
Keywords
Cervical cancer, miR-221, Gefitinib, PTEN
Journal
TUMOR BIOLOGY
Volume 37, Issue 3, Pages 3939-3947
Publisher
Springer Nature
Online
2015-10-19
DOI
10.1007/s13277-015-4247-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer
- (2015) Luo-Qiao Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study
- (2015) Chun-Chieh Wang et al. GYNECOLOGIC ONCOLOGY
- MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer
- (2015) Hyun Jin Bae et al. JOURNAL OF HEPATOLOGY
- miR-133a inhibits cervical cancer growth by targeting EGFR
- (2015) XUESONG SONG et al. ONCOLOGY REPORTS
- MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2
- (2015) Fan Yang et al. TUMOR BIOLOGY
- Role of microRNA221 in regulating normal mammary epithelial hierarchy and breast cancer stem-like cells
- (2015) Jia Ke et al. Oncotarget
- A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer
- (2014) Domenica Lorusso et al. GYNECOLOGIC ONCOLOGY
- Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer
- (2013) Israel Zighelboim et al. GYNECOLOGIC ONCOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A prospective phase II study of topotecan (Hycamtin®) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
- (2011) N. Manci et al. GYNECOLOGIC ONCOLOGY
- E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression
- (2011) M-T Lau et al. ONCOGENE
- MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
- (2010) Zhang Chun-zhi et al. BMC CANCER
- Alternative Splicing of Caspase 9 Is Modulated by the Phosphoinositide 3-Kinase/Akt Pathway via Phosphorylation of SRp30a
- (2010) J. C. Shultz et al. CANCER RESEARCH
- Epidermal Growth Factor Receptor Regulates MT1-MMP and MMP-2 Synthesis in SiHa Cells via Both PI3-K/AKT and MAPK/ERK Pathways
- (2010) Zongfeng Zhang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clinical significance of miR-221 and its inverse correlation with p27Kip1 in hepatocellular carcinoma
- (2010) Xinhui Fu et al. MOLECULAR BIOLOGY REPORTS
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
- MicroRNAs: Novel regulators in the hallmarks of human cancer
- (2009) Kai Ruan et al. CANCER LETTERS
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- Expression of HER-2 in MCF-7 breast cancer cells modulates anti-apoptotic proteins Survivin and Bcl-2 via the extracellular signal-related kinase (ERK) and phosphoinositide-3 kinase (PI3K) signalling pathways
- (2008) Aisha Siddiqa et al. BMC CANCER
- A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer
- (2007) A. Goncalves et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now